NASDAQ:HIT Health In Tech (HIT) Stock Price, News & Analysis $1.54 +0.02 (+1.32%) Closing price 04:00 PM EasternExtended Trading$1.54 +0.00 (+0.32%) As of 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Health In Tech Stock (NASDAQ:HIT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Health In Tech alerts:Sign Up Key Stats Today's Range$1.51▼$1.5850-Day Range$1.18▼$2.0352-Week Range$0.56▼$4.02Volume104,461 shsAverage Volume295,121 shsMarket Capitalization$92.34 millionP/E Ratio77.00Dividend YieldN/APrice Target$3.25Consensus RatingBuy Company Overview Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL. Read More Health In Tech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks30th Percentile Overall ScoreHIT MarketRank™: Health In Tech scored higher than 30% of companies evaluated by MarketBeat, and ranked 758th out of 878 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingBuy Consensus RatingHealth In Tech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialHealth In Tech has a consensus price target of $3.25, representing about 108.3% upside from its current price of $1.56.Amount of Analyst CoverageHealth In Tech has only been the subject of 2 research reports in the past 90 days.Read more about Health In Tech's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Health In Tech is 78.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.56.Price to Earnings Ratio vs. SectorThe P/E ratio of Health In Tech is 78.00, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 23.36. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.38% of the float of Health In Tech has been sold short.Short Interest Ratio / Days to CoverHealth In Tech has a short interest ratio ("days to cover") of 6.62.Change versus previous monthShort interest in Health In Tech has recently increased by 140.13%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth In Tech does not currently pay a dividend.Dividend GrowthHealth In Tech does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Health In Tech this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for HIT on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Health In Tech insiders have not sold or bought any company stock.Percentage Held by Insiders77.65% of the stock of Health In Tech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsHealth In Tech has minimal institutional ownership at this time.Read more about Health In Tech's insider trading history. Receive HIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health In Tech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HIT Stock News HeadlinesHealth In Tech Shifts Executive Role to Advisory PositionMay 1, 2026 | tipranks.comHealth In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026April 30, 2026 | prnewswire.comYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.May 5 at 1:00 AM | Profits Run (Ad)Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)April 30, 2026 | globenewswire.comHealth In Tech to Present at the Market Movers Investor SummitApril 21, 2026 | prnewswire.comThis ASX health tech stock just hit a new record high. Could it go even higher?April 17, 2026 | fool.com.auHealth In Tech Inc. Cl AApril 11, 2026 | barrons.comHealth In Tech Inc. - Ordinary Shares - Class AApril 8, 2026 | money.usnews.comSee More Headlines HIT Stock Analysis - Frequently Asked Questions How have HIT shares performed this year? Health In Tech's stock was trading at $1.59 at the beginning of 2026. Since then, HIT shares have decreased by 1.9% and is now trading at $1.56. How were Health In Tech's earnings last quarter? Health In Tech, Inc. (NASDAQ:HIT) announced its quarterly earnings data on Wednesday, March, 25th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.01). The company earned $7.51 million during the quarter. Read the conference call transcript. When did Health In Tech IPO? Health In Tech (HIT) raised $9 million in an IPO on the week of December 23rd 2024. The company issued 2,300,000 shares at a price of $4.00 per share. American Trust Investment Services acted as the underwriter for the IPO. How do I buy shares of Health In Tech? Shares of HIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/25/2026Today5/05/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 HIT's financial health is in the Green zone, according to TradeSmith. HIT has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Insurance Agents, Brokers & Service Sub-IndustryInsurance Current SymbolNASDAQ:HIT Previous SymbolNASDAQ:HIT CIK2019505 WebN/A Phone(888) 373-0333FaxN/AEmployees79Year FoundedN/APrice Target and Rating Average Price Target for Health In Tech$3.25 High Price Target$4.00 Low Price Target$2.50 Potential Upside/Downside+111.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio77.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$33.33 million Price / Sales2.77 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares59,958,000Free FloatN/AMarket Cap$92.34 million OptionableN/A Beta3.69 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:HIT) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health In Tech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health In Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.